Top compounds associated with response to SLC26A5


Feature Type Standardized
Nominal ANOVA
mRNA thapsigargin gCSI pan-cancer AAC -0.097 0.08
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.021 0.6
mRNA tigecycline CTRPv2 pan-cancer AAC 0.017 0.7
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.037 0.2
mRNA tivantinib CTRPv2 pan-cancer AAC 0.03 0.5
mRNA tivozanib GDSC1000 pan-cancer AAC 0.079 0.02
mRNA tivozanib CTRPv2 pan-cancer AAC -0.0074 0.8
mRNA tosedostat CTRPv2 pan-cancer AAC 0.048 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 5e-05
Download CSV